Lorraine M Sordillo Selected Research

Lorraine M Sordillo Research Topics

Disease

16	Inflammation (Inflammations) 01/2022 - 06/2009
9	Mastitis 01/2022 - 04/2011
4	Infections 05/2021 - 04/2011
3	Neoplasms (Cancer) 01/2019 - 08/2002
2	Diarrhea 04/2020 - 12/2016
2	Body Weight (Weight, Body) 07/2018 - 01/2013
2	Obesity 01/2017 - 04/2015
2	Endotoxemia 05/2016 - 05/2011
1	Uterine Diseases (Endometrial Disease) 01/2021
1	Colic (Abdominal Cramps) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Intestinal Volvulus (Volvulus) 01/2020
1	Osteoarthritis 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Cattle Diseases (Bovine Diseases) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Polyps 01/2019
1	Adenoma (Adenomas) 01/2019
1	Asymptomatic Infections 01/2017
1	Deltaretrovirus Infections (BLV Infection) 04/2014
1	Insulin Resistance 07/2013
1	Hypoglycemia (Reactive Hypoglycemia) 07/2013
1	Vascular Diseases (Vascular Disease) 05/2005
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2005
1	Breast Neoplasms (Breast Cancer) 01/2004

Drug/Important Bio-Agent (IBA)

6	LipidsIBA 01/2022 - 06/2009
6	Oxidants (Oxidizing Agents)IBA 05/2021 - 05/2005
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2017
4	Fatty Acids (Saturated Fatty Acids)IBA 05/2021 - 06/2009
4	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 04/2015
4	AcidsIBA 02/2020 - 01/2017
3	AntioxidantsIBA 01/2022 - 07/2018
3	13-hydroxy-9,11-octadecadienoic acidIBA 02/2020 - 01/2016
3	CytokinesIBA 01/2020 - 04/2011
3	Arachidonic Acid (Vitamin F)IBA 01/2019 - 01/2017
3	Hydroxyeicosatetraenoic Acids (HETE)IBA 01/2019 - 01/2017
2	NitrogenIBA 01/2022 - 07/2018
2	Oxygen (Dioxygen)IBA 01/2022 - 07/2018
2	IsoprostanesIBA 01/2022 - 05/2021
2	Pharmaceutical PreparationsIBA 05/2021 - 07/2013
2	Epoxide HydrolasesIBA 05/2021 - 01/2017
2	Linoleic Acid (Linoleate)IBA 02/2020 - 09/2015
2	ethyl pyruvateIBA 01/2020 - 05/2011
2	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 01/2019 - 01/2017
2	5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA 01/2019 - 01/2017
2	11-hydroxy-5,8,12,14-eicosatetraenoic acidIBA 01/2019 - 01/2017
2	Nonesterified Fatty Acids (NEFA)IBA 07/2018 - 09/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2016 - 04/2011
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2015 - 10/2013
2	Phospholipids (Phosphatides)FDA LinkGeneric 04/2015 - 10/2013
2	Selenoproteins (Selenoprotein)IBA 06/2014 - 01/2004
1	8-epi-prostaglandin F2alphaIBA 01/2022
1	EicosanoidsIBA 05/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2021
1	Analgesics (Analgesic Drugs)IBA 05/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2021
1	flunixin meglumine (Banamine)IBA 05/2021
1	AntipyreticsIBA 05/2021
1	EnzymesIBA 05/2021
1	Vitamin A (Retinol)FDA LinkGeneric 01/2021
1	Deltaretrovirus AntibodiesIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 04/2020
1	Phospholipases (Phospholipase)IBA 02/2020
1	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 01/2020
1	CytochromesIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	CopperIBA 01/2019
1	Lipoxygenase (Lipoxygenase-1)IBA 01/2019
1	LipoxygenasesIBA 01/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	Eicosapentaenoic AcidIBA 01/2019
1	RhodanineIBA 01/2019
1	HaptoglobinsIBA 07/2018
1	Arachidonic AcidsIBA 01/2017
1	Inflammation MediatorsIBA 01/2017
1	Docosahexaenoic AcidsIBA 01/2017
1	Epoxy Compounds (Epoxides)IBA 01/2017
1	Neutralizing AntibodiesIBA 12/2016
1	InterleukinsIBA 05/2016
1	Interleukin-8 (Interleukin 8)IBA 05/2016
1	LipopolysaccharidesIBA 05/2016
1	13-hydroperoxy-9,11-octadecadienoic acidIBA 01/2016
1	AntibodiesIBA 04/2014
1	Glucose (Dextrose)FDA LinkGeneric 07/2013
1	Sodium Salicylate (Salicylate, Sodium)IBA 07/2013
1	SalicylatesIBA 07/2013
1	Trace Elements (Biometals)IBA 01/2013
1	SeleniumIBA 01/2013
1	Bacterial VaccinesIBA 04/2011
1	15- hydroperoxy- 5,8,11,13- eicosatetraenoic acidIBA 05/2005
1	Caspase 3 (Caspase-3)IBA 05/2005
1	Caspase 9IBA 05/2005
1	ChromatinIBA 05/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2004

Therapy/Procedure

4	Therapeutics 05/2021 - 05/2011
1	Operative Time 01/2020
1	Subcutaneous Injections 01/2013